ProShares S&P 500 Aristocrats ETF (BATS:NOBL – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The company traded as high as $97.36 and last traded at $97.22, with a volume of 230848 shares. The stock had previously closed at $97.36. ProShares S&P 500 Aristocrats ETF Stock Up 0.3 […]
CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 53,100 shares, a growth of 14.7% from the April 30th total of 46,300 shares. Currently, 0.8% of the shares of the company are […]
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note issued to investors on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright cut their price objective on shares of CASI Pharmaceuticals from $12.00 to $6.00 and set a buy rating on […]
StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reduced their price objective on CASI Pharmaceuticals from $12.00 to $6.00 and set a buy rating on the stock in a […]
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright lowered their price objective on CASI Pharmaceuticals from $12.00 to $6.00 and set a buy rating on the stock […]